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Summary 
Background Access to diagnosis and dialysis for acute kidney injury can be life-saving, but can be prohibitively 
expensive in low-income settings. The burden of acute kidney injury in sub-Saharan Africa is presumably high but 
remains unknown. We did a systematic review to assess outcomes of acute kidney injury in sub-Saharan Africa and 
identify barriers to care.
Methods We searched PubMed, African Journals Online, WHO Global Health Library, and Web of Science for articles 
published between Jan 1, 1990, and Nov 30, 2014. We scored studies, and all were of medium-to-low quality. We made 
a pragmatic decision to include all studies to best reﬂ ect reality, and did a descriptive analysis of extracted data. This 
study is registered with PROSPERO, number CRD42015015690.
Findings We identiﬁ ed 3881 records, of which 41 met inclusion criteria, including 1403 adult patients and 
1937 paediatric patients. Acute kidney injury in sub-Saharan Africa is severe, with 1042 (66%) of 1572 children and 
178 (70%) 253 of adults needing dialysis in studies reporting dialysis need. Only 666 (64%) of 1042 children (across 
11 studies) and 58 (33%) of 178 adults (across four studies) received dialysis when needed. Overall mortality was 34% 
in children and 32% in adults, but rose to 73% in children and 86% in adults when dialysis was needed but not 
received. Major barriers to access to care were out-of-pocket costs, erratic hospital resources, late presentation, and 
female sex. 
Interpretation Patients in these studies are those with resources to access care. In view of overall study quality, data 
interpretation should be cautious, but high mortality and poor access to dialysis are concerning. The global scarcity of 
resources among patients and health centres highlights the need for a health-system-wide approach to prevention 
and management of acute kidney injury in sub-Saharan Africa.
Funding None.
Copyright © Olowu et al. Open Access article distributed under the terms of CC BY. 
Introduction
Acute kidney injury is associated with substantial morbidity 
and mortality worldwide, but data have been conspicuously 
missing from the Global Burden of Disease study.1 Acute 
kidney injury refers to any sudden decline in kidney 
function, which can be reversible if detected early enough. 
Acute kidney injury can be community-acquired, resulting 
from an injury or infection before admission to hospital, or 
can be hospital-acquired, arising as a compli cation of 
hospital admission. Community-acquired acute kidney 
injury tends to occur in low-income countries, and in 
young people with few comorbidities, whereas hospital-
acquired acute kidney injury tends to occur in high-income 
settings, and in older people (45–80 years), often with 
several comor bidities.2 The burden of acute kidney injury 
in sub-Saharan Africa is unknown, but mortality is 
presumably high because of poor access to health care. 
In a world meta-analysis,3 the pooled incidence of acute 
kidney injury was 21·0% in adults and 33·7% in children, 
and mortality was 23·3% in adults and 13·8% in children. 
Only one of 154 included studies was from sub-Saharan 
Africa.3 Most studies included patients with 
hospital-acquired acute kidney injury, contrasting with 
most acute kidney injury in sub-Saharan Africa, which is 
community-acquired.3 Mortality was lower in countries 
with higher expenditure on health care, reﬂ ecting 
improved access to health care and dialysis in these 
countries.3 In an update of this analysis, incidence and 
outcomes from 62 African studies were summarised in a 
table, but again excluded from the broader analysis.2 The 
generalisability of these global ﬁ ndings to sub-Saharan 
Africa is therefore unknown.
Despite the absence of data for disease burden, the 
drive towards providing universal dialysis for acute 
kidney injury, which can be life-saving, is growing. In 
much of sub-Saharan Africa, dialysis is paid for out of 
pocket, at an estimated US$300 per episode of acute 
kidney injury for a child, and probably more for an adult.4 
In our experience, many patients cannot meet such costs 
and are forced to decline treatment. If provision of 
dialysis is to be sustainable in sub-Saharan Africa, data 
are needed to inform health policy decisions. In view of 
the present absence of epidemiological data, we have 
undertaken a systematic review to assess reported 
outcomes in patients with acute kidney injury in sub-
Saharan Africa to highlight the real-world context of 
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acute kidney injury in the region and to identify barriers 
to care that should be tackled to comprehensively address 
this important problem. This systematic review is highly 
relevant to understanding the challenges faced in 
management of acute kidney injury in sub-Saharan 
Africa, which are a crucial component of the disease 
burden.
Methods 
Search strategy and selection criteria 
We did a systematic review using the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines (appendix).5 We 
searched PubMed, African Journals Online, the WHO 
Global Health Library, and Web of Science with 
relevant medical subject headings (appendix). We 
selected additional references through bibliographies 
from identiﬁ ed articles. We restricted the search to 
articles in English or French, published between Jan 1, 
1990, and Nov 30, 2014. Outcomes of interest included 
access to dialysis, mortality, and recovery of renal 
function in cohorts of all patients admitted to hospital 
with acute kidney injury, irrespective of cause. We 
included variable deﬁ nitions of acute kidney injury 
(clinical [oliguria, hyperkalaemia, or metabolic 
acidosis]; laboratory [urea or creatinine]; standardised 
diagnostic criteria; and need for dialysis). We excluded 
articles focusing exclusively on cohorts with single 
causes of acute kidney injury (eg, malaria), since 
outcomes would not be generalisable to the broader 
acute kidney injury population.2 We excluded case 
reports. FAA and VAL screened titles and abstracts for 
eligibility. Articles meeting inclusion criteria and 
obtainable as full texts were reviewed in detail. This 
study is registered with PROSPERO, number 
CRD42015015690.
Figure 1: Study selection
*WHO Global Health Library includes African Index Medicus.
3881 records identiﬁed
 161 from African Journals Online
 1023 from PubMed
 922 from Web of Science
 1775 from WHO Global Health Library*
261 articles excluded 
 28 speciﬁc causes of kidney disease
 1 conference abstract
 8 donors
 6 data not relevant
 65 guidelines, reviews, editorials, or commentaries 
 10 studied prevalence or incidence 
 68 outcomes too speciﬁc (eg, peritonitis rates, tuberculosis in dialysis)
 8 papers reported the same populations 
 4 paediatric chronic kidney disease and end-stage renal disease
 46 adult chronic kidney disease and end-stage renal disease
 17 transplant 
3070 titles and abstracts screened 
19 adult acute kidney injury
  9 medium quality 
 10 low quality
22 paediatric acute kidney injury
 11 medium quality 
 11 low quality 
302 full text articles assessed for eligibility
41 articles selected for systematic review
7 studies from 1990–2009 15 studies from 2010–14 9 studies from 1990–2009 10 studies from 2010–14
811 duplicates excluded
2764 records excluded (data not 
 relevant)
33 not available in full text
29 records identiﬁed from other 
  sources 
See Online for appendix
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Quality assessment and data extraction
The quality of each study was assessed independently by 
two authors (VAL plus one of: WAO, AN, CO, GA, or 
FAA) using a checklist modiﬁ ed from Stanifer and 
colleagues6 (appendix). Most studies were observational 
case series. Because no study met high-quality criteria 
(predominantly because no study represented all patients 
with acute kidney injury, and many did not describe 
inclusion or exclusion rates or missing data), rather than 
excluding almost all identiﬁ ed articles, we decided not to 
exclude any articles, to minimise bias and reﬂ ect reality as 
much as possible. Half of studies met medium-quality 
criteria (appendix). Data from individual studies were 
extracted into a Microsoft Excel database for analysis.
Data analysis
Because data were not uniform, we reported results with a 
descriptive approach and narrative synthesis.7,8 We 
stratiﬁ ed data into adult and paediatric groups and 
analysed them separately. Where possible, we reported 
pooled estimates of outcome frequencies combining all 
studies, in parallel with means of reported individual study 
frequencies to show variability of reported outcomes.8 We 
analysed diﬀ erences in means with t tests and comparisons 
of proportions using the χ² test. More than half of the 
studies were published since 2010; therefore, to assess 
outcomes and detect changes over time, we further 
stratiﬁ ed data by publication before or after 2010.
We did descriptive statistics using Microsoft Excel and 
Statistics to Use.9
Role of the funding source
There was no funding source for this study.
Results
We identiﬁ ed 3070 studies through the literature search 
once duplicates were excluded. After screening titles and 
abstracts, we assessed 302 studies for eligibility (ﬁ gure 1). 
42 studies10–50 from 13 countries satisﬁ ed inclusion criteria, 
reporting outcomes in all children and adults admitted to 
hospital with acute kidney injury. Two studies reported on 
the same patient cohort, therefore only the study with the 
most outcomes was included. Eight studies were 
prospective, 32 were retrospective, and one was cross-
sectional. Studies are outlined in detail in the appendix. 
13 adult and six paediatric studies included only patients 
Adult studies Paediatric studies
1990–2009 2010–14 p 1990–2009 2010–14 p
Total number of studies 9 10 ·· 7 15 ··
Countries 6 5 ·· 3 6 ··
Patient inclusion period 1972–2007 1996–2013 ·· 1985–2004 2000–13 ··
Total patients with 
acute kidney injury 
studied (pooled)
639 764 ·· 720 1217 ··
Study duration (years) 5·2 (6·3) 4·9 (5·8) ·· 11·3 (6·3) 4·8 (3·0) ··
Male patients (pooled) 339/601 (56%; n=8) 329/627 (52%; n=6) 0·17 459/713 (64%; n=6) 514/927 (55%; n=9) <0·0001
Male/female ratio 
(means of individual 
studies)
1·5 (0·8) 1·2 (0·3) 0·31 1·9 (0·6) 1·3 (0·6) 0·14
Deﬁ nitions of acute 
kidney injury used 
(number of studies) 
9 9 0·14 6 11 0·023
Clinical 1 0 ·· 1 1 ··
Laboratory (urea or 
creatinine)
5 2 ·· 1 0 ··
Laboratory and clinical 0 0 ·· 4 1 ··
(p)RIFLE, AKIN, or 
ADQI
0 3 ·· 0 4 ··
Dialysis need 3 4 ·· 0 5 ··
Clinical presentations (means of individual studies) 
Oliguria* 59·83% (SD 23·82, n=3) 67·25% (SD 18·58, n=4) 0·66 68·73% (SD 29·00, n=3) 73·02% (SD 8·1, n=6) 0·73
Hyperkalaemia† 30·4% (n=1) 25·10% (SD 23·6, n=3) ·· 13·95% (SD 12·80, n=2) 28·60%  (SD 15·60, n=4) ··
Metabolic acidosis‡ No data 53·87% (SD 20·44, n=3) ·· 20·10% (SD 16·97, n=2) 42·20% (SD 26·51, n=3) ··
Data are number of studies, mean (SD), or percentage of patients (number of studies with outcome). p values reported for time periods 1990–2009 versus 2010–14. 
(p)RIFLE=(paediatric) risk, injury, failure, loss of function, and end-stage renal disease. AKIN=Acute Kidney Injury Network. ADQI=Acute Dialysis Quality Initiative. *Oliguria 
deﬁ ned as urine output <400 mL per 24 h in adults, <300 mL per 24 h or <1 mL/kg/h in children, anuria, or not deﬁ ned. †Deﬁ nitions of hyperkalaemia variable, ≥5·5 mmol/L, 
≥6·5 mmol/L, or not deﬁ ned. ‡Deﬁ nitions of metabolic acidosis variable, ≤10 mmol/L, ≤15 mmol/L, or not deﬁ ned.  
 Table 1: Acute kidney injury study populations
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with acute kidney injury who received or needed dialysis; 
two adult studies included intensive care unit populations; 
and two adult studies included a small proportion of 
paediatric patients. Pooled studies included patients 
enrolled between April, 1972, and December, 2013. 
Study populations are outlined in table 1. Pooled patients 
with acute kidney injury included 1403 adults and 
1937 children. Six adult and nine paediatric studies described 
patients presenting with predominantly community-
acquired acute kidney injury, and two paediatric studies 
reported the proportions of community-acquired acute 
kidney injury to be 72·8% and 82·9%.14,16 In the remaining 
studies, most cases were probably community-acquired. 
Children ranged from birth to age 17 years, and mean age in 
adult studies ranged from 28·7 years to 44·4 years (appendix). 
The pooled proportion of male patients was signiﬁ cantly 
larger than that of female patients (57% men; p=0·005). 
Male predominance did not change in adults, but declined 
signiﬁ cantly in children over time (table 1). Reported 
frequencies of hyperkalaemia, metabolic acidosis, and 
oliguria are outlined in table 1. Acute kidney injury was 
attributed to intrinsic renal disease in 200 (pooled 56%) of 
359 adults (across four studies) and 200 (pooled 41%) of 
491 children (across six studies; data not shown). Detailed 
causes of acute kidney injury are shown in table 2. In adults 
Children 
(n=1643)* 
Adults 
(n=993)†
Infection 380 (23%) 274 (28%)
Septicaemia 370 232
HIV 6 0
Tetanus 4 1
Pyelonephritis 0 12
Typhoid 0 7
Cholera 0 22
Glomerular disease 350 (21%) 76 (8%)
Acute glomerulonephritis 183 57
Nephrotic syndrome 115 10
Rapidly progressive acute 
glomerulonephritis
46 4
Lupus nephritis 5 5
Membranoproliferative acute 
glomerulonephritis
1 0
Nephrotoxin    270 (16%) 182 (18%)
Haemoglobinuria from: 
Plasmodium falciparum malaria 
haemolysis
198 34
G6PD deﬁ ciency haemolysis 18 0
Infection 0 41
Transfusion reaction 0 2
Autoimmune haemolytic 
anaemia
2 0
Herbal remedies ingestion 6 8
Holy water 0 7
Henna (para-phenylenediamine) 0 12
Unspeciﬁ ed drugs 0 17
Furosemide 5 0
ACE inhibitors 5 0
Cytotoxic drugs 5 0
Unspeciﬁ ed 31 61
Intravascular volume depletion or 
hypoperfusion 
174 (11%) 50 (5%)
Gastroenteritis 169 42
Inadequate volume replacement 
before and after surgery
4 0
Severe haemorrhage 1 0
Unspeciﬁ ed 0 8
Obstructive uropathy 146 (9%) 46 (5%)
Renal stone 60 16
(Table 2 continues in next column)
Children 
(n=1643)* 
Adults 
(n=993)†
(Continued from previous column)
Congenital anomaly of the kidney and the urinary tract
Posterior urethral valves 32 0
Renal agenesis    4 0
Prune belly syndrome 1 0
Prostate 0 9
Malignancy 0 2
Schistosoma 0 2
Unspeciﬁ ed 49 17
Vascular disease or haemolysis 116 (7%) 11 (1%)
Haemolytic uraemic syndrome 111 1
Thrombotic thrombocytopenic 
purpura
2 0
Purpura fulminans 1 0
Renal vein thrombosis 1 1
Sickle cell crisis 1 0
Haemolysis, other 0 9
Medical, other 0 36 (4%)
Liver disease 0 15
Cardiac 0 8
Malignant hypertension 0 13
Malignancy 40 (2%) 19 (2%)
Birth asphyxia 27 (2%) 0
Obstetric or gynaecological 0 157 (16%)
Septic abortion 0 66
Pre-eclampsia or eclampsia 0 43
Pre-partum or post-partum 
haemorrhage
0 30
Ureter ligation after hysterectomy 0 7
Unspeciﬁ ed 0 11
Surgical 0 54 (5%)
Trauma, burns, or fractures 0 43
Postoperative 0 1
Other 0 10
Unspeciﬁ ed 140 (9%) 88 (9%)
G6PD=glucose-6-phosphate dehydrogenase. ACE=angiotensin converting enzyme. 
*17 paediatric studies. †14 adult studies. 
Table 2: Causes of acute kidney injury in children and adults
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and children, infection, including malaria, accounted for 
more than 30% of acute kidney injury.
Delays of up to 3 weeks between onset of symptoms and 
presentation to hospital were described in three adult 
studies.31,36,38 One paediatric study reported a mean delay of 
6 days between symptom onset and presentation, and two 
studies described delay in presentation among 50–80% of 
children (appendix).11,15,29  
Deﬁ nitions used for diagnosis of acute kidney injury 
have changed over time (table 1). Standardised diagnostic 
criteria for acute kidney injury (risk, injury, failure, loss of 
function, and end-stage renal disease [RIFLE] and 
paediatric RIFLE [pRIFLE]; Acute Kidney Injury Network 
[AKIN]; and Acute Dialysis Quality Initiative) were used 
in 35% of studies that reported deﬁ nitions used published 
after 2010 compared with none before 2010. 
1075 adults and 609 children received dialysis (table 3). 
Haemodialysis predominated among adults (969 [90%] of 
1075) and peritoneal dialysis predominated among children 
(568 [80%] of 709). 19 of the 41 studies included only patients 
who needed or received dialysis and therefore could not be 
used to calculate dialysis indication or access rates. 
Access to dialysis was deﬁ ned as the proportion of 
patients with acute kidney injury who received dialysis 
when indicated (table 3). In four studies, 178 of 253 adults 
needed dialysis, giving a pooled dialysis indication rate of 
70%. Among these 178 adults, the pooled dialysis access 
rate was 33%. The mean dialysis access rate across adult 
studies was 49·1% (SD 42·3). 11 studies reported dialysis 
need in 1042 of 1572 children with acute kidney injury, 
giving a pooled dialysis indication rate of 66% (table 3). 
In these 1042 children, the dialysis access rate was 64%. 
The mean dialysis access rate across studies was 45·0% 
(SD 32·8; range 9·7–100). In pooled analyses, dialysis 
indication rate and dialysis access rate in children 
increased signiﬁ cantly over time (table 3; p<0·0001). 
However, when data from South Africa and Sudan 
(countries with government-sponsored dialysis and 
paediatric acute kidney injury access rates of 100% and 
95%, respectively) were excluded from this analysis, the 
pooled dialysis access rate after 2010 decreased to 31% 
(156 of 509 children received dialysis), which does not 
diﬀ er signiﬁ cantly from the rate before 2010.
One study described a delay of 3·3 days (SD 1·9; 
range 1–9) between admission to hospital and initiation 
of dialysis owing to the search for resources to pay for 
dialysis, others reported patient deaths while the search 
for resources was underway, or patients leaving hospital 
against medical advice because of inability to aﬀ ord 
dialysis (appendix).13,25,45 
Mortality was reported in 17 adult studies and 21 paediatric 
studies (table 4). Of 1077 adults, 346 died, giving a pooled 
mortality of 32%. Of 1842 children, 627 died, giving a 
pooled mortality of 34%. Pooled mortality decreased 
signiﬁ cantly in both adults and children over time, although 
the ranges of individual study mortalities were highly 
variable (p<0·0001). Mortality associated with speciﬁ c 
causes of acute kidney injury is shown in the appendix.
When stratiﬁ ed by whether dialysis, when indicated, was 
received or not, pooled mortality was signiﬁ cantly higher 
in adults (86% vs 30%; p<0·0001) and children (74% vs 
30%; p<0·0001) who did not receive at least one dialysis 
session. Nine studies reported consistent ﬁ ndings in 
adults and children from the same cohort, suggesting this 
may not merely be a centre eﬀ ect (appendix). Mortality in 
children was not diﬀ erent between those who received 
haemodialysis and those who received peritoneal dialysis. 
Overall mortality reported in children with acute kidney 
injury who did not need dialysis was lower than in those 
who received dialysis (16·22% vs 28·54%; p=0·13). 
Major predictors of poor outcomes in several studies 
were late presentation and inability to pay for dialysis.18,36 
Numbers of patients lost to follow-up or leaving against 
medical advice were high in some studies (table 4), 
showing the challenges of patient care and clinical 
research in sub-Saharan Africa. 
Renal recovery, deﬁ ned as independence from dialysis, 
improvement in serum creatinine after acute kidney injury, 
Adult studies Paediatric studies
1990–2009 2010–14 p 1990–2009 2010–14 p
Dialysis distribution ·· ·· <0·0001 ·· ·· 0·57
Haemodialysis 411 (82%; n=8)  558 (97%; n=8) ·· 5 (4%; n=2) 114 (20%; n=5) ··
Peritoneal dialysis 86 (17%; n=2) 17 (3%; n=1) ·· 122 (96%; n=6) 446 (77%; n=8) ··
Both 1 (<1%) 0 ·· 0 22 (4%; n=1) ··
CRRT 2 (<1%) 0 ·· ·· ·· ··
Studies with dialysis received as an inclusion criterion* 5 8 ·· 0 6  ··
Indication for dialysis in acute kidney injury (pooled) 94/132 (71%; n=3) 84/121 (69%; n=1) 0·76 372/608 (61%; n=5) 670/964 (70%; n=6) 0·001
Access to dialysis (pooled) 44/94 (47%) 14/84 (17%) ·· 119/372 (32%) 547/670 (82%)† <0·0001
Access to dialysis (means of individual studies) 59·8% (SD 44·2) 16·7% ·· 34·2% (SD 37·2) 54·0% (SD 28·9) 0·35
Data are number of patients (%) or number of studies. p values for 1990–2009 versus 2010–14. CRRT=continuous renal replacement therapy. *Studies with dialysis required or received as an inclusion criterion 
provided no information on non-dialysed patients or patients with acute kidney injury who did not need dialysis and therefore were excluded from this analysis. †When two studies from South Africa and Sudan 
are excluded, the dialysis access rate decreases to 31% and does not diﬀ er between 1990–2009 and 2010–14. 
Table 3: Indication for dialysis and access to dialysis in children and adults with acute kidney injury 
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or both, was reported in 17 studies (table 4). The pooled rate 
of renal recovery was 130 (55%) of 237 (six studies) in adult 
survivors and 667 (75%) of 886 (11 studies) in child 
survivors. The pooled rate of residual chronic kidney 
disease, deﬁ ned as persistence of renal dysfunction but not 
needing dialysis at time of discharge, was 24 (13%) of 
186 adults (three studies) and 68 (10%) of 676 children (ﬁ ve 
studies). These outcomes were not routinely reported or 
systematically deﬁ ned, and some studies had substantial 
loss to follow-up, so the true rates remain unknown.
Discussion 
The aim of this systematic review was to describe the 
real-world context of patients diagnosed with acute 
kidney injury in sub-Saharan Africa. We identiﬁ ed 
41 studies published during 25 years reporting access to 
dialysis when needed, mortality, and renal outcomes in 
cohorts of all patients with acute kidney injury. 
Most patients presented with severe acute kidney injury, 
with 70% of adults and 66% of children needing dialysis 
(stage 3 acute kidney injury). This dialysis need contrasts 
strongly with the pooled world need for dialysis in patients 
with acute kidney injury of 11%, because 80% of all 
patients worldwide had stage 1 (mild) acute kidney injury.4 
These opposing observations suggest that acute kidney 
injury is a more aggressive disorder in sub-Saharan Africa 
than elsewhere; however, this is more likely to be a result 
of late presentation to hospital and reliance on clinical 
criteria for diagnosis, which might only become apparent 
at an advanced stage. Many studies commented on delay 
in patient presentation, not uncommonly with oliguria 
and advanced uraemia at diagnosis.
When dialysis was needed, the pooled dialysis access 
rate was 33% in adults and 64% in children, although 
rates were as low as 10% in some studies. Results of a 
survey of availability of paediatric services in Nigeria 
showed that more than 50% of facilities did not have 
dialysis capability.51 When patients did gain access to 
dialysis, most adults received haemodialysis, showing the 
absence of peritoneal dialysis in many centres.32,34,36 In 
Adult studies Paediatric studies
1990–2009  2010–14  p 1990–2009 2010–14  p
Overall mortality
Mortality (pooled) 237/639 (37%; n=9) 109/438 (25%; n=8) <0·0001 285/720 (40%; n=7) 342/1122 (30%; 
n=14)
<0·0001
Mortality (means of individual studies) 38·7% (20·6) 29·2% (24·5) 0·40 40·5% (8·3) 30·4% (14·4) 0·11
Mortality without dialysis when needed
Mortality without dialysis when needed 
(pooled)
43/50 (86%; n=2) NA ·· 179/247 (72%; n=4) 45/57 (79%; n=3) 0·32
Mean mortality without dialysis (means of 
individual studies) 
82·4% (12.8) NA ·· 72·9% (18·8) 90·0% (17·3) 0·27
Mortality with dialysis
Mortality with dialysis (pooled) 161/500 (32%; n=8) 78/288 (27%; n=6) 0·13 28/119 (24%; n=5) 184/585 (31%; 
n=10)
0·09
Mean mortality with dialysis (means of 
individual studies) 
28·0% (15·7) 35·1% (26·1) 0·54 16·4% (11·5) 34·6% (20·1) 0·09
Mean mortality haemodialysis (means of 
individual studies) 
27·3% (14·13; n=7) 33·46 % (27·00; n=6) 0·61 57·0% (39·9; n=3)  0·27*
Mean mortality peritoneal dialysis (means 
of individual studies) 
25% (n=1)  NA NA 33·6% (27·4; n=9)  ··
Mortality when dialysis not indicated
Mortality when dialysis not indicated 
(pooled)
23/43 (53%†; n=2) NA ·· 36/232 (16%; n=4) 43/285 (15%; n=4) 0·84
Mortality, acute kidney injury not needing 
dialysis (means of individual studies)
30·3% (42·8) NA ·· 22·2% (17·1) 10·2% (8·4) 0·25
Other outcomes
Recovery of renal function in survivors 
(pooled)
58/78 (74%; n=2) 72/159 (45%; n=4) <0·0001 152/172 (88%; n=3) 515/714 (72%; n=8) <0·0001
Residual chronic kidney disease in survivors 
(pooled)‡
6/73 (8%; n=1) 18/113 (16%; n=2) 0·1 23/143 (16%; n=2) 45/533 (8%; n=3) 0·007
Left hospital against medical advice (pooled) 0 6/62 (10%; n=1) ·· 10/183 (5%; n=2) 33/814 (4%; n=5) 0·4
Lost to follow-up (pooled) 28/264 (11%; n=2) 6/17 (35%; n=1) ·· 116/334 (35%; n=2) 20/700 (3%; n=2) <0·0001
Data are mean % (SD) or mean (%; number of studies with outcome). p values for 1990–2009 versus 2010–14. *Comparison between haemodialysis and peritoneal dialysis in 
children. †One study included high-comorbidity patients in intensive care units. ‡Chronic kidney disease not speciﬁ cally deﬁ ned, generally non-requirement for dialysis but 
non-return of renal function to normal parameters by discharge or loss to follow-up. 
Table 4: Outcomes in children and adults with acute kidney injury
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children, peritoneal dialysis predominated, owing to body 
size limitations and absence of haemodialysis facilities.11,23,28 
Paediatric peritoneal dialysis was some times done with 
modiﬁ ed alternative catheters and ﬂ uids when appropriate 
resources were unavailable.23
The overall pooled mortality was 32% in adults and 
34% in children with acute kidney injury. These rates are 
much higher than the pooled world rates of 23·3% in 
adults and 13·8% in children, possibly showing the 
increased severity of documented acute kidney injury in 
sub-Saharan Africa and low access to dialysis.3 The more 
than two times higher mortality in children in sub-
Saharan Africa compared with worldwide mortality is 
especially concerning. How the overall data might be 
skewed by the high proportion of studies exclusively on 
dialysed patients is diﬃ  cult to predict. Pooled mortality 
in those who received dialysis was 30% in adults and 
children, lower than the world mortality among dialysed 
patients with acute kidney injury of 46%.2 The lower 
dialysis mortality in sub-Saharan Africa compared with 
elsewhere might reﬂ ect the relative absence of patient 
comorbidities and more frequent community-acquired 
acute kidney injury, despite frequent premature 
discontinuation of dialysis because of cost.38
However, a substantial proportion of patients with 
acute kidney injury in sub-Saharan Africa did not receive 
dialysis when needed and experienced very high mortality 
rates. These poor outcomes show the severity of patient 
illness and delayed presentation, delays imposed by 
searching for funds after admission to hospital, and the 
erratic infrastructure.13,18,29,38,45 However, mortality among 
these undialysed patients was not inevitable, emphasising 
the value of conservative management and prompt 
treatment of underlying disease in the absence of 
dialysis.24 Availability of the needed resources might also 
be inconsistent in sub-Saharan Africa. Resources 
reported during the included studies are listed in the 
appendix. A survey of 66 intensive care facilities in the 
Democratic Republic of the Congo reported that 
crystalloids were available in 100% of units, but that 
availability of antibiotics and other necessities was 
variable.52 Serum creatinine was never available in 75·8% 
of units. Dialysis was not available in any units. 
Most adults and children surviving acute kidney injury 
recovered renal function, although roughly 10% had 
residual renal dysfunction. This high rate of persistent 
renal dysfunction might be a result of the initial severity 
of acute kidney injury, or might highlight the challenges 
in excluding underlying chronic kidney disease without 
access to diagnostic tests. Very few cohorts had long-term 
follow-up, therefore these percentages could be an 
overestimate and some patients might have continued to 
improve over time.
Several barriers to access to care for acute kidney injury 
were identiﬁ ed through this study, as shown in ﬁ gure 2. 
First, the low overall patient numbers reported suggest 
that many patients with acute kidney injury are not 
diagnosed or treated. Second, male patients predominate, 
probably showing some discrimination against women. 
Third, poor patient resources led to delays in admission 
to hospital and use of traditional medicine, which might 
be especially harmful in the setting of dehydration, for 
example, and worsen kidney injury. Fourth, delays occur 
in referral from peripheral health-care sites to sites where 
renal care is available. Finally, delays occur after 
admission to hospital because patients need to search for 
funds to pay for dialysis or because supplies, staﬃ  ng, or 
resources of the hospital are erratic. Each of these delays 
might have a seemingly obvious cause, but if a holistic 
approach is to be taken to prevent acute kidney injury, 
much research, including clinical, epidemiological, and 
anthropological study, is needed to investigate all 
contributors to such barriers. The expectation that most 
patients can pay for dialysis, even when heavily 
subsidised, is probably unrealistic, since even meagre 
user-fees are a hindrance to access to basic health care in 
low-income settings.53 The predominance of male 
Figure 2: Barriers to care in acute kidney injury
Outcomes shown for each pathway (survival or death) are the most likely outcomes, but are not inevitable 
(table 4).
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patients might reﬂ ect a true increased susceptibility to 
renal disease (eg, urogenital abnormalities in boys), but 
more probably reﬂ ects the relative absence of economic 
and decision-making power among women, and is 
consistent with ﬁ ndings in other low-resource regions.54,55 
Although reported observations seem to be mostly 
consistent across studies, this systematic review has 
substantial limitations. In most countries in sub-Saharan 
Africa, access to diagnosis and specialist renal care for 
acute kidney injury is scarce, and is heavily reliant on 
out-of-pocket payments by patients. The patients reported 
in the reviewed studies are therefore those who had the 
resources to be diagnosed with acute kidney injury, some 
of whom were also able to access dialysis. These studies 
do not represent the many patients with acute kidney 
injury in sub-Saharan Africa for whom the needed health 
services are beyond reach.
The observational and historical nature of most studies, 
coupled with a high proportion of missing data, frequent 
patient loss to follow-up, variability in acute kidney injury 
deﬁ nitions, and representation of data from only 
13 countries all diminish the robustness of data 
interpretation. Such weaknesses have led to exclusion of 
these studies from existing meta-analyses, and acute 
kidney injury in sub-Saharan Africa has therefore 
remained a so-called black box in the world scientiﬁ c 
literature on acute kidney injury. Our decision to include 
all obtainable studies was intentional to try to mitigate 
publication bias that would be exacerbated with further 
study selection, and to best capture the reality of daily 
challenges faced by patients and nephrologists in sub-
Saharan Africa. Our inclusion of all comers also 
strengthens the generalisability of the ﬁ ndings to the 
general acute kidney injury population. However, 
descriptive analysis cannot account for diﬀ erent study 
weights or quality, and the conclusions are therefore less 
robust than in a meta-analysis. The severity of reported 
acute kidney injury might show a bias towards testing 
the most symptomatic patients, which could overestimate 
poorer outcomes, although patients who survived the 
delay in presentation to hospital might have a propensity 
to survival. Abstracts of nine acute kidney injury articles 
were not obtainable in full text, but the outcomes 
described suggest consistency with the main ﬁ ndings of 
this study and would therefore be unlikely to alter the 
conclusions.
Highlighting real-world outcomes and challenges, 
despite study limitations, is important to inform health-
systems-wide planning and policy development for acute 
kidney injury in regions where resources are scarce and 
many health-care priorities are competing. The increasing 
number of publications over time highlights growing 
expertise, but also an urgency in the specialty. This study 
also highlights the important limitations of previous 
studies. Study quality scores and checklists should be 
considered prospectively in any ongoing or planned 
research on acute kidney injury in sub-Saharan Africa to 
optimise study design, data collection, and accuracy of 
reporting, so that future studies can further understanding 
of the true burden of acute kidney injury in sub-Saharan 
Africa and reliably inform policy making. 
The published outcomes of acute kidney injury in 
patients in sub-Saharan Africa show the complexities of 
access to timely and appropriate renal care in the region. 
Several barriers to diagnosis and care of acute kidney 
injury are evident, the most consistent of which are 
delays in reaching hospital, cost of care, erratic 
functioning or supply of hospital resources, and female 
sex. If a programme for prevention and treatment of 
acute kidney injury is to be eﬀ ective and sustainable, 
each barrier will need to be understood and overcome.
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